Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Total Current Liabilities: 2017-2023

Historic Total Current Liabilities for Solid Biosciences (SLDB) over the last 7 years, with Dec 2023 value amounting to $14.5 million.

  • Solid Biosciences' Total Current Liabilities rose 44.50% to $22.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $22.9 million, marking a year-over-year increase of 44.50%. This contributed to the annual value of $14.5 million for FY2023, which is 35.50% down from last year.
  • Latest data reveals that Solid Biosciences reported Total Current Liabilities of $14.5 million as of FY2023, which was down 35.50% from $22.5 million recorded in FY2022.
  • Solid Biosciences' 5-year Total Current Liabilities high stood at $24.5 million for FY2020, and its period low was $14.5 million during FY2023.
  • Moreover, its 3-year median value for Total Current Liabilities was $22.5 million (2022), whereas its average is $20.2 million.
  • Per our database at Business Quant, Solid Biosciences' Total Current Liabilities spiked by 46.43% in 2019 and then plummeted by 35.50% in 2023.
  • Over the past 5 years, Solid Biosciences' Total Current Liabilities (Yearly) stood at $18.3 million in 2019, then surged by 33.95% to $24.5 million in 2020, then dropped by 3.59% to $23.6 million in 2021, then dropped by 4.63% to $22.5 million in 2022, then tumbled by 35.50% to $14.5 million in 2023.